Aqilion strengthens the company’s Alnitak pharmaceutical project in chronic inflammation through closer collaboration with Örebro University researchers
Aqilion announced today that the company has initiated an expanded collaborative effort with Professor Eva Särndahl and Senior Lecturer Alexander Persson at the School of Medical Sciences, Örebro University in Sweden. Aqilion focuses on diseases in which chronic inflammation is an important component in the disease process. Inflammation is one of the body’s defense mechanisms against harmful factors such as bacteria, viruses, or mechanical damage to cells. There are various types of inflammatory conditions. Inflammation may be acute in nature, such as when fighting a viral infection. Or